SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Epigral - Quaterly Results

22 Apr 2024 Evaluate
A decrease in the sales to Rs. 5246.33 millions was observed for the quarter ended March 2024. The sales stood at Rs. 5621.77 millions during the similar quarter previous year.A slender decline of -0.17% was recorded to Rs. 766.70  millions from Rs. 767.99 millions in the corresponding previous quarter.Operating Profit reported a sharp decline to 1569.15 millions from 1592.51 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 5246.33 5621.77 -6.68 19291.92 21884.00 -11.84 19291.92 21884.00 -11.84
Other Income 15.23 45.38 -66.44 65.15 79.84 -18.40 65.15 79.84 -18.40
PBIDT 1569.15 1592.51 -1.47 4877.26 6969.81 -30.02 4877.26 6969.81 -30.02
Interest 136.87 189.88 -27.92 734.89 655.02 12.19 734.89 655.02 12.19
PBDT 1432.28 1402.63 2.11 4142.37 6314.79 -34.40 4142.37 6314.79 -34.40
Depreciation 303.76 301.30 0.82 1235.64 1089.53 13.41 1235.64 1089.53 13.41
PBT 1128.52 1101.33 2.47 2906.73 5225.26 -44.37 2906.73 5225.26 -44.37
TAX 361.82 333.34 8.54 948.84 1691.69 -43.91 948.84 1691.69 -43.91
Deferred Tax 162.45 132.52 22.59 421.74 748.61 -43.66 421.74 748.61 -43.66
PAT 766.70 767.99 -0.17 1957.89 3533.57 -44.59 1957.89 3533.57 -44.59
Equity 415.50 415.50 0.00 415.50 415.50 0.00 415.50 415.50 0.00
PBIDTM(%) 29.91 28.33 5.58 25.28 31.85 -20.62 25.28 31.85 -20.62

Epigral Share Price

1295.00 -32.55 (-2.45%)
11-May-2026 16:01 View Price Chart
Peers
Company Name CMP
BASF India 3865.25
Tata Chemicals 761.95
SRF 2793.80
Pidilite Inds. 1437.80
Deepak Nitrite 1858.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×